September 15, 2010 – A study evaluating the level of platelet aggregation achieved after switching from clopidogrel (Plavix) 75 mg once-daily maintenance dosing plus aspirin to prasugrel (Effient) 10 mg once-daily maintenance dosing (MD) in patients with acute coronary syndrome (ACS) was published today in the Journal of the American College of Cardiology.

September 15, 2010 – The U.S. Food and Drug Administration (FDA) has extended the time to complete its review of the new drug application (NDA) for ticagrelor (Brilinta), which is the first reversible oral antiplatelet drug.

September 15, 2010 – A high-definition intravascular ultrasound (IVUS) system will be demonstrated during the Transcatheter Cardiovascular Therapeutics (TCT) 2010 symposium Sept. 21-25 in Washington, D.C.


September 14, 2010 – Transcatheter valves, drug-eluting balloons and the latest stent comparison trial data are among the top three trends at Transcatheter Cardiovascular Therapeutics (TCT) 2010 scientific sessions Sept. 21-25 in Washington, D.C.

September 14, 2010 –To support proactive patient care for those at risk for worsening heart failure, Medtronic this week introduced the CareLink Network for Heart Failure. The remote monitoring system is an extension of the current CareLink system for implantable cardiac device monitoring system. The new system will be available this fall.

September 14, 2010 – The latest clinical trial data for the Promus Element and Taxus Element coronary stents will be released during the Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, Sept. 21–25, in Washington, D.C.

September 10, 2010 – Cath Labs are being encouraged this week by the U.S. Food and Drug Administration (FDA) to inspect their inventories for AngioSculpt EX Percutaneous Transluminal Coronary Angioplasty (PTCA) Scoring Balloon Catheters. Devices manufactured between Jan. 30 and Dec. 4, 2009 are part of a class 1 product recall due to safety concerns.

September 10, 2010 – The U.S. Food and Drug Administration (FDA) is requiring that gadolinium-based contrast agents (GBCAs) carry new warnings on their labels about the risk of a rare and potentially fatal condition known as nephrogenic systemic fibrosis (NSF). The condition may occur if the drug is administered to certain patients with kidney disease.

September 10, 2010 – With new tax on medical devices beginning in 2013, a guidewire original equipment manufacturer (OEM) believes this may dampen future funding for research and development. However, Lake Region Medical said it may offer greater opportunities to partner with the larger vendors it supplies as they try to make advancements in non-core products, such as guidewires.

September 10, 2010 – The first patient was successfully supported for six days by the Impella Right Peripheral (RP) ventricular assist device (VAD) at the Providence Heart and Lung Institute at St. Paul’s Hospital in Vancouver, British Columbia. This is the first use of the Impella RP.

Subscribe to
Β© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now